Original Research

Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome

Davies MJ, Merton KW, Vijapurkar U, Balis DA, Desai M

Diabetes, Metabolic Syndrome and Obesity 2017, 10:47-55

Published Date: 27 January 2017